YURY GADAYEV: Open Payments
NPI 1841371796 · ENGLEWOOD, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,191 in 179 payments from 30 companies in 2025. Trend: 2023 $2,539 · 2024 $2,945 · 2025 $4,191
Food & beverage: $4,077Education: $114
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 40 | $588 |
| ARGENX US, INC. | 28 | $502 |
| ABBVIE INC. | 23 | $355 |
| Lilly USA, LLC | 7 | $352 |
| Cycle Pharmaceuticals Inc | 12 | $270 |
| Teva Pharmaceuticals USA, Inc. | 8 | $220 |
| SK Life Science, Inc. | 6 | $196 |
| GENZYME CORPORATION | 3 | $194 |
| Janssen Biotech, Inc. | 3 | $170 |
| ANI Pharmaceuticals, Inc. | 4 | $164 |
Products named: VYVGART HYTRULO, NURTEC ODT, KISUNLA, Sajazir, AUSTEDO XR, QULIPTA, PURIFIED CORTROPHIN GEL, VYVGART.
Industry payments across CO — which companies pay providers there.
